Differences in Ventilation Management and Outcomes between the Two First Waves of the COVID-19 Pandemic-A Comparison between Two Nationwide Observational Studies in The Netherlands.
COVID-19
complications
coronavirus disease 2019
invasive ventilation
ventilation management
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
05 Jul 2023
05 Jul 2023
Historique:
received:
07
04
2023
revised:
12
06
2023
accepted:
03
07
2023
medline:
14
7
2023
pubmed:
14
7
2023
entrez:
14
7
2023
Statut:
epublish
Résumé
The aim of this analysis was to compare ventilation management and outcomes in invasively ventilated patients with acute hypoxemic respiratory failure due to coronavirus disease 2019 (COVID-19) between the first and second wave in the Netherlands. This is a post hoc analysis of two nationwide observational COVID-19 studies conducted in quick succession. The primary endpoint was ventilation management. Secondary endpoints were tracheostomy use, duration of ventilation, intensive care unit (ICU) and hospital length of stay (LOS), and mortality. We used propensity score matching to control for observed confounding factors. This analysis included 1122 patients from the first and 568 patients from the second wave. Patients in the second wave were sicker, had more comorbidities, and had worse oxygenation parameters. They were ventilated with lower positive end-expiratory pressure and higher fraction inspired oxygen, had a lower oxygen saturation, received neuromuscular blockade more often, and were less often tracheostomized. Duration of ventilation was shorter, but mortality rates were similar. After matching, the fraction of inspired oxygen was lower in the second wave. In patients with acute hypoxemic respiratory failure due to COVID-19, aspects of respiratory care and outcomes rapidly changed over the successive waves.
Identifiants
pubmed: 37445542
pii: jcm12134507
doi: 10.3390/jcm12134507
pmc: PMC10342245
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Amsterdam University Medical Centers
ID : NA
Organisme : Netherlands Organisation for Health Research and Development
ID : 10430102110008
Références
N Engl J Med. 2021 Apr 22;384(16):1491-1502
pubmed: 33631065
Intensive Care Med. 2020 May;46(5):854-887
pubmed: 32222812
Stat Med. 2009 Nov 10;28(25):3083-107
pubmed: 19757444
JAMA Otolaryngol Head Neck Surg. 2021 Mar 1;147(3):239-244
pubmed: 33331855
J Infect. 2021 Apr;82(4):84-123
pubmed: 33152376
Expert Rev Respir Med. 2021 Dec;15(12):1619-1625
pubmed: 34311634
PLoS One. 2021 Oct 28;16(10):e0258918
pubmed: 34710120
Cochrane Database Syst Rev. 2021 Mar 30;3:CD009098
pubmed: 33784416
JAMA. 2012 Jun 20;307(23):2526-33
pubmed: 22797452
Crit Care. 2021 Apr 6;25(1):128
pubmed: 33823862
Lancet. 2020 Jun 6;395(10239):1763-1770
pubmed: 32442528
Infect Dis (Lond). 2021 May;53(5):370-375
pubmed: 33560897
Ann Transl Med. 2021 May;9(9):813
pubmed: 34268426
N Engl J Med. 2021 Feb 25;384(8):693-704
pubmed: 32678530
PLoS One. 2022 Feb 9;17(2):e0263001
pubmed: 35139089
Lancet. 2021 May 01;397(10285):1637-1645
pubmed: 33933206
N Engl J Med. 2019 May 23;380(21):1997-2008
pubmed: 31112383
JAMA. 2016 Feb 23;315(8):788-800
pubmed: 26903337
Acute Med. 2021;20(2):92-100
pubmed: 34190735
Br J Anaesth. 2021 Aug;127(2):e73-e75
pubmed: 34090679
Crit Care. 2021 Mar 16;25(1):106
pubmed: 33726819
Intensive Care Med. 2020 Dec;46(12):2200-2211
pubmed: 32728965
JAMA. 2020 Sep 8;324(10):998-1000
pubmed: 32789492
Int J Crit Illn Inj Sci. 2022 Jan-Mar;12(1):4-9
pubmed: 35433394
Eur J Anaesthesiol. 2021 Dec 1;38(12):1274-1283
pubmed: 34238782
J Investig Med. 2021 Dec;69(8):1479-1482
pubmed: 34518318
Intensive Care Med. 2021 Jan;47(1):60-73
pubmed: 33211135
PLoS One. 2021 Mar 31;16(3):e0248029
pubmed: 33788866
Ann Transl Med. 2020 Oct;8(19):1251
pubmed: 33178783
Sci Rep. 2022 Sep 14;12(1):15406
pubmed: 36104383